Department of Surgery, Stanford University, 453 Quarry Road, Stanford, Palo Alto, CA, 94304, USA.
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Langenbecks Arch Surg. 2024 Mar 12;409(1):93. doi: 10.1007/s00423-024-03282-3.
Pilonidal disease (PD) significantly impacts patients' quality of life and requires regular maintenance behaviors to achieve cure. Health mindset is a psychological construct which can influence health behaviors and outcomes, with a growth mindset being associated with better outcomes than a fixed. We propose that participation in a standardized treatment protocol can affect the health mindset for adolescents with pilonidal disease.
PD patients' demographics, recurrence, and comorbidities were prospectively collected from 2019 to 2022. We assessed patients' mindset score at initial presentation using the validated Three-Item Mindset Scale (1-6) then reassessed during follow-up. t-test was used to compare baseline and follow-up mindset scores and stratified by recurrence or comorbidities. p ≤ 0.05 was considered significant.
A total of 207 PD patients (108 males, 99 females) with mean age 18.2 ± 3.7 years were followed for 351 ± 327 days. Mean baseline mindset score (4.76 ± 1.27) was significantly lower than mean follow-up mindset score (5.03 ± 1.18, p = 0.049). Baseline mindset score was significantly lower among patients with PD recurrence (4.00 ± 0.66) compared to those without recurrence (4.8 ± 1.29, p = 0.05). Among patients with PD recurrence, mean baseline mindset score (4.00 ± 0.66) was significantly lower than mean follow-up mindset score (5.27 ± 0.93, p = 0.0038). Patient comorbidity did not affect the baseline or follow-up mindset score.
Participation in a standardized treatment protocol is associated with the development of a stronger growth mindset over time for patients with PD. Furthermore, a growth mindset was linked to lower recurrence rate than a fixed mindset. Further investigations into how treatment approaches can work in concert with health mindset are proposed.
藏毛窦病(PD)显著影响患者的生活质量,需要进行定期的维持治疗以达到治愈。健康心态是一种心理结构,它可以影响健康行为和结果,具有成长心态的人比具有固定心态的人预后更好。我们提出,参与标准化治疗方案可以影响患有藏毛窦病的青少年的健康心态。
从 2019 年到 2022 年,前瞻性地收集 PD 患者的人口统计学、复发和合并症数据。我们在初次就诊时使用经过验证的三项目心态量表(1-6 分)评估患者的心态评分,然后在随访期间再次评估。采用 t 检验比较基线和随访时的心态评分,并根据复发或合并症进行分层。p≤0.05 被认为有统计学意义。
共纳入 207 例 PD 患者(108 例男性,99 例女性),平均年龄 18.2±3.7 岁,随访 351±327 天。平均基线心态评分(4.76±1.27)显著低于平均随访时的心态评分(5.03±1.18,p=0.049)。与无复发患者相比,有 PD 复发的患者(4.00±0.66)的基线心态评分显著更低(4.8±1.29,p=0.05)。有 PD 复发的患者,平均基线心态评分(4.00±0.66)显著低于平均随访时的心态评分(5.27±0.93,p=0.0038)。患者合并症不影响基线或随访时的心态评分。
参与标准化治疗方案与 PD 患者随着时间的推移发展出更强烈的成长心态有关。此外,成长心态与固定心态相比,复发率更低。建议进一步研究治疗方法如何与健康心态协同作用。